Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01205789 · ClinicalTrials.gov registry record
EXCEL Clinical Trial (Universal Registry)
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 1,000
- Enrollment target
NCT01205789 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 1,000 participants.
The verdict
NCT01205789 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 1,000 participants
- Enrollment target
Study Summary
The purpose of the Universal Registry is to assess the proportion and reasons for which subjects with angiographically significant ULMCA disease requiring revascularization during the time course of this study are not randomized; to compare the baseline characteristics of subjects; and to assess the variability in randomization eligibility and treatment patterns.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2010-10 |
| Est. Completion | 2012-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01205789
The ClinicalTrials.gov registry entry for NCT01205789 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01205789 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01205789 about?
NCT01205789 is a clinical study titled "EXCEL Clinical Trial (Universal Registry)". The purpose of the Universal Registry is to assess the proportion and reasons for which subjects with angiographically significant ULMCA disease requiring revascularization during the time course of this study are not randomized; to compare the baseline characteristics of subjects; and to assess the...
What is the current status of trial NCT01205789?
This trial is currently completed. The enrollment target is 1,000 participants. The study started on 2010-10. Estimated completion is 2012-09.
Who is sponsoring clinical trial NCT01205789?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.